ROCHELLE MARIE HANLEY
Medical Practice in Ann Arbor, MI
License number
Michigan 4301075402
Issued Date
Nov 22, 1999
Expiration Date
Jan 31, 2017
Category
Medicine
Type
Medical Doctor
Address
Address
Ann Arbor, MI 48105
Personal information
See more information about ROCHELLE MARIE HANLEY at radaris.comName
Address
Phone
3412 E Dobson Pl, Ann Arbor, MI 48105
3412 Dobson Pl, Ann Arbor, MI 48105
Professional information
Method For Preventing And Treating Skin Aging
US Patent:
2002019, Dec 26, 2002
Filed:
Dec 5, 2001
Appl. No.:
10/007158
Inventors:
Jane Brandman - Madison NJ, US
Rochelle Hanley - Ann Arbor MI, US
Rochelle Hanley - Ann Arbor MI, US
International Classification:
A61K031/56
US Classification:
424/401000, 514/171000
Abstract:
Skin aging and acne are prevented and treated with a composition comprising an estrogen and a progestin.
Dr. Rochelle M Hanley, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
3412 E Dobson Pl, Ann Arbor 48105
Certifications:
Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Mi Med Sch
Graduated: 1978
St Lukes Episcopal Hospital
Baylor Coll Med Affil Hosp
U Tex
University of Mi Med Sch
Graduated: 1978
St Lukes Episcopal Hospital
Baylor Coll Med Affil Hosp
U Tex
Methods For The Treatment Of Erectile Dysfunction Using Fispemifene
US Patent:
2013021, Aug 22, 2013
Filed:
Mar 21, 2013
Appl. No.:
13/848325
Inventors:
Robert L. Zerbe - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Assignee:
QuatRX Pharmaceuticals Company - Ann Arbor MI
International Classification:
A61K 31/085, A61K 31/519, A61K 31/4985
US Classification:
514250, 514720, 51425216
Abstract:
A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.
Methods For The Treatment Of Erectile Dysfunction Using Fispemifene
US Patent:
2008031, Dec 18, 2008
Filed:
Jun 13, 2008
Appl. No.:
12/138560
Inventors:
Robert L. Zerbe - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Assignee:
QUATRX PHARMACEUTICALS COMPANY - Ann Arbor MI
International Classification:
A61K 31/53, A61K 31/085, A61K 31/135, A61P 15/00, A61K 31/4985, A61K 31/496
US Classification:
514243, 514720, 514648, 51425216, 514250
Abstract:
A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.
Methods For The Treatment Of Erectile Dysfunction Using Fispemifene
US Patent:
2010026, Oct 14, 2010
Filed:
Jun 8, 2010
Appl. No.:
12/795986
Inventors:
Robert L. Zerbe - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Alexander Bridges - Saline MI, US
Risto Lammintausta - Turku, FI
Rochelle Hanley - Ann Arbor MI, US
Stuart Dombey - Ann Arbor MI, US
Assignee:
QUATRX PHARMACEUTICALS COMPANY - Ann Arbor MI
International Classification:
A61K 31/497, A61P 15/10
US Classification:
51425216
Abstract:
A method of treatment of erectile dysfunction (ED) comprises the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Methods are also disclosed of treating ED by administering clomifene, enclomifene, ospemifene, toremifene and mixtures thereof in combination with a PDE-5 inhibitor.